DexCom, Inc. Historical Return Calculator: 10-Year ROI & Dividend Growth

Investment Scenario

DexCom, Inc. share price on Jan 1, 2015  

Share Price          : $14.94
Total Share Bought   : 669 shares
Invested Amount      : $9994.86

In 2015, an investor has $10,000.00 and wants to invest in DexCom, Inc. (DXCM). At that time, the stock price of DexCom, Inc. is $14.94 per share, allowing the investor to purchase 669 shares for a total of $9994.86. This leaves the investor with $5.14 remaining from the initial $10,000.00.
Instead of chasing short-term gains, the investor adopted a long-term approach—holding the shares for 10 years without selling. Over time, the value of the investment grew not only through stock price appreciation but also through the accumulation of dividend payouts.

DexCom, Inc. share price on Sep 2, 2025 

Share Price       : $74.3
Total Share       : 2676 shares (including stock splits, if any) 
Portfolio Value   : $198,826.80

As of Sep 2, 2025, the $9,994.86 investment in NASDAQ:DXCM would be worth approximately $198,826.80 , thanks to stock splits, price appreciation, and consistent dividend payouts. This reflects a total Gain from stocks of $188,831.94, a return on investment (ROI) of 1889.29%, and an annualized compounded growth rate (CAGR) of around 34.86%. This highlights the power of long-term investing and shows how a disciplined, patient approach—paired with investing in a fundamentally strong company like DexCom, Inc. (DXCM)—can lead to significant wealth creation over time.

Wealth grew over time through a mix of dividend income and stock price appreciation. Dividends added to capital, while stock splits increased the number of shares held. Even without reinvesting dividends, the portfolio expanded steadily. As years passed, compounding took effect — turning small gains into larger ones. Holding the stock long-term allowed capital to grow naturally. This shows how patience, steady returns, and the power of compounding can help build lasting wealth from a single investment.

DexCom, Inc. Investment Summary (2015–2025)

   
 
 By Sep 2, 2025, the share price increased to $74.30.
 This resulted in a significant appreciation in the value of the investment.
 

 

This performance reflects a Compound Annual Growth Rate (CAGR) of DexCom, Inc. stock, approximately 34.86% 
 — a strong return over the period.

Yearly Breakdown

DXCM 10 years Investment Performance Overview

DexCom, Inc. (Ticker: DXCM) is a 0.029T (Large-Cap) Medical Devices company in the Healthcare sector, listed on the NASDAQ. With a market capitalization of $0.029T (Large-Cap), a PE ratio of 52.32, and an EPS of 1.42, DXCM remains one of American’s most stable and well-established companies.

If we have a look at DXCM's stock performance in last one year, it has traded between a 52-week low of $57.52 and a high of $93.25 per share.

If you had invested $9,994.86 in DexCom, Inc. (DXCM) 10 years ago, your portfolio would have grown significantly by Sep 2, 2025:

• Initial investment: $9,994.86
• Stock Gain: $188.8K (~ 1.9 Lakh)
• Total Dividends received: $0.00
• Total return (Stock Gain + Dividends): $188,831.94
• Final Portfolio Value (Initial + Stock Gain + Dividends): $198,826.80

This journey shows that DXCM has not only delivered steady capital appreciation but also rewarded shareholders through consistent dividend payouts, making it a strong long-term wealth compounder in the American stock market.